Rosuvastatin Completed Phase 3 Trials for Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00251680Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.